Argusaze Trademark Details
Word Mark | Argusaze |
---|---|
Status | Dead 606 — Abandoned - No Statement of Use Filed |
Current Owner
Serial Number | 78628732 |
---|---|
Status Date | Wednesday, April 18, 2007 |
Filing Date | Wednesday, April 18, 2007 |
Attorney | Nadine P. Flynn |
Correspondent
NADINE P. FLYNN
BRISTOL-MYERS SQUIBB COMPANY
345 PARK AVE
NEW YORK, NY 10154-0004
BRISTOL-MYERS SQUIBB COMPANY
345 PARK AVE
NEW YORK, NY 10154-0004
Case File Statements
Goods & Services | Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, and pharmaceutical antibody; diagnostic pharmaceutical preparations for human use for increasing the heart rate and contrast imaging agents |
---|
Classifications
International Class Codes |
005
|
---|---|
U.S. Class Codes | 006, 018, 044, 046, 051, 052 |
Status | 6 — Active |
Status Date | Thursday, May 19, 2005 |
Primary Code | 005 |
Trademark Timeline
-
May 12 2005Trademark application filed with USPTO
-
May 19 2005New Application Entered In Tram
-
Dec 08 2005Assigned To Examiner
-
Dec 20 2005Priority Action Written
-
Dec 21 2005Priority Action Mailed
-
Apr 06 2006Correspondence Received In Law Office
-
Apr 06 2006Teas Response To Office Action Received
-
Apr 12 2006Teas/email Correspondence Entered
-
Apr 14 2006Approved For Pub - Principal Register
-
Apr 21 2006Assigned To Lie
-
May 16 2006Assigned To Examiner
-
Jun 08 2006Law Office Publication Review Completed
-
Jul 05 2006Notice of Publication
-
Jul 25 2006Published For Opposition
-
Oct 17 2006Noa Mailed - Sou Required From Applicant
-
Jun 20 2007Abandonment - No Use Statement Filed
-
Jun 21 2007Abandonment Notice Mailed - No Use Statement Filed